Abstract: Disclosed herein is a composition for modulating immunity, comprising Lactobacillus paracasei LT12, ?-glucan, and Bovine Colostrum Powder. Also provided is a method for modulating immunity, comprising administering to a subject in need a therapeutically effective amount of the composition, wherein the method is to enhance the expression of IL-6, IL-10, TNF-? and TGF-?1.

Abstract: Provided herein is a pharmaceutical composition comprising 1-2 part by weight of Schisandra chinensis powder and 5-10 part by weight of extract of Psidium guajava L. The composition can be used in the treatment of reducing blood uric acid, protecting pancreatic beta cell, and reducing body fat.

Abstract: A laminate for inhibiting ethylene response in plants comprises at least one layer of a polymer composition and at least one layer of a paper substrate. The polymer composition comprises an agent that blocks binding sites for ethylene response in plants, a solvent having slight solvency or no solvency, and a polymer or copolymer soluble in the solvent and water. Also disclosed are methods of preparing the same, methods for preparing the paper substrate laminate, and methods for inhibiting ethylene response in plants. An aluminum foil-based or corrugated board-based laminate for inhibiting ethylene response in plants comprises at least one layer of a polymer composition and at least one layer of aluminum foil or corrugated board. The polymer composition comprises an agent that blocks binding sites for ethylene response in plants, a solvent having slight solvency or no solvency, and a polymer or copolymer soluble in the solvent and water.

Abstract: Disclosed is a microcapsule composition for inhibiting an ethylene response in plants, which comprises a plurality of microcapsules, each including an agent for blocking an ethylene binding site in plants in an oil droplet, and a coating encapsulating the oil droplet and the agent for blocking the ethylene binding site in plants. A method for preparing microcapsules of an agent for blocking the ethylene binding site in plants, and a method for inhibiting an ethylene response in plants are also disclosed.

Abstract: An isolated Lactobacillus paracasei strain LT12 and its genetically-engineered variant that possesses immune regulating activity and uses thereof for regulating immune responses and treating allergy.

Abstract: An isolated Lactobacillus paracasei strain LT12 and its genetically-engineered variant that possesses immune regulating activity and uses thereof for regulating immune responses and treating allergy.

Abstract: Disclosed is a microcapsule composition for inhibiting an ethylene response in plants, which comprises a plurality of microcapsules, each including an agent for blocking an ethylene binding site in plants in an oil droplet, and a coating encapsulating the oil droplet and the agent for blocking the ethylene binding site in plants. A method for preparing microcapsules of an agent for blocking the ethylene binding site in plants, and a method for inhibiting an ethylene response in plants are also disclosed.

Abstract: The present invention relates to a composition comprising an effective amount or an effective amount of one or more dipeptides consisting of histidine or the functional equivalent thereof and alanine or the functional equivalent thereof for reducing uric acid in a subject. The invention also provides a method for the treatment of gout or the amelioration of symptoms related to a high level of uric acid comprising the step of administering or applying the above-mentioned dipeptides to a subject.

Abstract: The present invention relates to a chitosan-embedded or encapsulated capsule, which comprises a chitosan content which is chitosan, a salt thereof, or a derivative thereof, and an edible gum embedding or encapsulating the content.

Abstract: Disclosed is a tablet dosage for inhibiting ethylene response in a plant containing a blocking agent, which has ethylene binding site inhibition activity to plants, and an effervescent ingredient in admixture with one or more acceptable excipients. A process of preparing the tablet dosage and a method for inhibiting ethylene response in plants are also disclosed therein.